Lisdexamfetamine Dimesylate 65162-0023
Generic: Lisdexamfetamine
Product NDC
65162-0023- Manufacturer
- Amneal Pharmaceuticals Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- August 28, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA202830
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 20 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
90 CAPSULE in 1 BOTTLE (65162-023-09)